Gilead Sciences, Inc (GILD) current stock price is $112.46. During the last trading session, the stock soared, reaching $140.0 after opening at $112.46. The stock’s lowest point was $91.0 before it closed at $114.51. The market performance of Gilead Sciences, Inc has been somewhat stable.
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded an increase of 56.50%. However, over the last six months,
In terms of market performance, Gilead Sciences, Inc had a fairly even. The highest value for the stock in the past year was $119.96 on 03/10/25, and the lowest value was recorded at $66.01 on 07/05/24. 52-week price history of GILD Stock A stock’s 52-week
Gilead Sciences, Inc’s market performance has been stable in recent times. 52-week price history of GILD Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Gilead Sciences, Inc’s current trading
Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Gilead Sciences, Inc’s current trading price is -9.18% away from its 52-week high, while its distance from the 52-week low
Gilead Sciences, Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $119.96 on 03/10/25, and the lowest price during that time was $62.07, recorded on 05/31/24. 52-week price history of GILD Stock A stock’s 52-week high and low
In terms of market performance, Gilead Sciences, Inc had a somewhat regular. The highest value for the stock in the past year was $119.96 on 03/10/25, while the lowest value was $62.07 on 05/31/24. 52-week price history of GILD Stock Analyzing the 52-week price history
The healthcare firm Gilead Sciences Inc. (GILD) has lost nearly 5 percent of its stock over the past year. This arose even after the company’s drug was approved for COVID-19 therapy. Gilead Sciences specializes in the prevention of HIV as well as infectious diseases, including
All rights reserved © 2024, Powered By Smart TechOne